Mar, 1 2026

Identifying Problem Generics: When Pharmacists Should Flag Issues

Generics save billions, but not all are safe. Pharmacists must know when to flag problematic versions - especially for NTI drugs, complex formulations, or after manufacturer switches. Here’s how to spot the risks and act.

Read More

Jan, 17 2026

Orange Book Database: FDA's Approved Drug Products With Therapeutic Equivalence Evaluations

The FDA's Orange Book lists approved drugs and their generic equivalents, showing which ones can be safely substituted. It's the key to understanding patent expirations, exclusivity, and how generics enter the market.

Read More